佐力药业：2025年第一次临时股东大会决议公告

Group 1 - The core point of the article is that Zhaoli Pharmaceutical announced the approval of several proposals, including the amendment of the company's articles of association, during its first extraordinary general meeting of shareholders in 2025 [2] Group 2 - The announcement was made on the evening of September 5, indicating the company's ongoing governance and regulatory compliance efforts [2] - The approval of the proposals reflects the company's strategic direction and potential future initiatives [2]